Advisory Committee on Immunization Practices (ACIP), 43995 [2010-18403]

Download as PDF Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices in at the security desk upon entering the building. (Catalogue of Federal Domestic Assistance Program Nos. 93.701, ARRA Related Biomedical Research and Research Support Awards; 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: July 21, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting sroberts on DSKD5P82C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel, Healthy Aging; Search for Mechanisms. Date: August 6, 2010. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Ramesh Vemuri, PhD, Chief, Scientific Review Branch, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C– 212, Bethesda, MD 20892, 301–402–7700, rv23r@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: July 21, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–18384 Filed 7–26–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 16:30 Jul 26, 2010 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES management activities for both the CDC and ATSDR. Centers for Disease Control and Prevention Dated: July 21, 2010. Michael J. Lanzilotta, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices (ACIP) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: [FR Doc. 2010–18386 Filed 7–26–10; 8:45 am] 43995 Time and Date: 10 a.m.–12 p.m., August 5, 2010. Place: The conference call will originate at the National Center for Immunization and Respiratory Diseases in Atlanta, Georgia. Please see SUPPLEMENTARY INFORMATION for details on accessing the conference call. Status: Open to the public, limited only by the availability of telephone ports. Purpose: The Committee is charged with advising the Director, CDC, on the appropriate use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding appropriate dosing intervals, dose, and contraindications to use of vaccines. Matters To Be Discussed: To discuss recommendations for use of CSL trivalent inactivated influenza vaccine (TIV) for use in the United States during 2010–2011. Supplementary Information: This conference call is scheduled to begin at 10 a.m., Eastern Daylight Time, United States. To participate in the conference call, please dial 1–800–857–9629 and reference passcode 3908107. As provided under 41 CFR 102– 3.150(b), the public health urgency of this agency business requires that the meeting be held prior to the first available date for publication of this notice in the Federal Register. CONTACT PERSON FOR MORE INFORMATION: Leola Mitchell, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., Mailstop E05, Atlanta, Georgia 30333, telephone 404/639–8836, fax 404/639–8905, e-mail acip@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 [FR Doc. 2010–18403 Filed 7–26–10; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HOMELAND SECURITY Federal Emergency Management Agency [Docket ID: FEMA–2010–0026] Agency Information Collection Activities: Submission for OMB Review; Comment Request, OMB No. 1660–0046; FEMA/EMI Independent Study Course Enrollment and Test Answer Sheet Federal Emergency Management Agency, DHS. ACTION: Notice; 30-day notice and request for comments; revision of a currently approved information collection; OMB No. 1660–0046; FEMA Form 064–0–9 (formerly 95–23), FEMA/ EMI Independent Study Course Enrollment and Test Answer Sheet (paper and electronic). AGENCY: The Federal Emergency Management Agency (FEMA) will submit the information collection abstracted below to the Office of Management and Budget for review and clearance in accordance with the requirements of the Paperwork Reduction Act of 1995. The submission will describe the nature of the information collection, the categories of respondents, the estimated burden (i.e., the time, effort and resources used by respondents to respond) and cost, and the actual data collection instruments FEMA will use. DATES: Comments must be submitted on or before August 26, 2010. ADDRESSES: Submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the Desk Officer for the Department of Homeland Security, Federal Emergency Management Agency, and sent via electronic mail to oira.submission@omb.eop.gov or faxed to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: Requests for additional information or SUMMARY: E:\FR\FM\27JYN1.SGM 27JYN1

Agencies

[Federal Register Volume 75, Number 143 (Tuesday, July 27, 2010)]
[Notices]
[Page 43995]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18403]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:

    Time and Date: 10 a.m.-12 p.m., August 5, 2010.
    Place: The conference call will originate at the National Center 
for Immunization and Respiratory Diseases in Atlanta, Georgia. Please 
see SUPPLEMENTARY INFORMATION for details on accessing the conference 
call.
    Status: Open to the public, limited only by the availability of 
telephone ports.
    Purpose: The Committee is charged with advising the Director, CDC, 
on the appropriate use of immunizing agents. In addition, under 42 
U.S.C. 1396s, the Committee is mandated to establish and periodically 
review and, as appropriate, revise the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) program, along with schedules regarding appropriate 
dosing intervals, dose, and contraindications to use of vaccines.
    Matters To Be Discussed: To discuss recommendations for use of CSL 
trivalent inactivated influenza vaccine (TIV) for use in the United 
States during 2010-2011.
    Supplementary Information: This conference call is scheduled to 
begin at 10 a.m., Eastern Daylight Time, United States. To participate 
in the conference call, please dial 1-800-857-9629 and reference 
passcode 3908107.
    As provided under 41 CFR 102-3.150(b), the public health urgency of 
this agency business requires that the meeting be held prior to the 
first available date for publication of this notice in the Federal 
Register.

CONTACT PERSON FOR MORE INFORMATION: Leola Mitchell, National Center 
for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., 
Mailstop E05, Atlanta, Georgia 30333, telephone 404/639-8836, fax 404/
639-8905, e-mail acip@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the CDC and ATSDR.


    Dated: July 21, 2010.
Michael J. Lanzilotta,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2010-18403 Filed 7-26-10; 8:45 am]
BILLING CODE 4160-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.